Financial toxicity in cancer care

O’Connor, Joanne; Kircher, Sheetal Mehta; Souza, Jonas A. de

doi:10.12788/jcso.0239

Cited by 44 publications

(46 citation statements)

References 46 publications

(93 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Regardless of the reasons, it is significant that two out of three women worried about the costs of cancer care and that economic issues were the main components of what they worried about. This is in line with current literature that calls attention to financial and economic implications as another side effect of cancer treatment [18–21]. The implications these may have for the well-being of women with ovarian cancer, and how to address them, needs to be investigated.…”

Section: Discussionsupporting

confidence: 79%

Values and worries of ovarian cancer patients

Pisu

Kenzik

Rim

et al. 2017

Gynecologic Oncology

View full text Add to dashboard Cite

Introduction Older women with ovarian cancer (OC) are less likely to receive guideline concordant treatment. Differences in values and worries about treatment may explain why. Methods Women with OC in 2013–2015 were surveyed about values and worries at the time of initial treatment. Existing values (11 item, e.g., maintaining quality of life) and worries (12 items, e.g., treatment side effects) scales were adapted based on OC literature. Responses were very/somewhat/a little/not at all important or worried. Principal Component Analyses (PCA) identified groups of values and worries that best explained scales' variation. We examined proportions reporting very/somewhat important/worried on ≥1 item in each component by age (older ≥65 years, younger <65 years). Results Of 170 respondents, 42.3%were older. PCA components for values were: functional well-being (3 survey items, proportion of variance explained [PoVE] 26.3%), length of life and sexual functioning (3 items, PoVE 20.1%), attitudes (3 items, PoVE 14.2%), and not becoming a burden (2 items, PoVE 13.7%). PCA components for worries were: economic (4 items, PoVE 27.2%), uncertainty (6 items, PoVE 26.0%), and family impact (2 items, PoVE 16.3%). Older women were less likely to indicate very/somewhat worried to ≥1 item in the economic (51.4% vs 72.4%, p = 0.006), uncertainty (80.6% vs. 98.0%, p = 0.001), and family impact component (55.6% vs. 70.4%, p = 0.03). No other age differences were found. Conclusions While worry during OC treatment decision-making may differ across age groups, values do not. Research should assess how differences in worry might affect OC medical decision-making for older and younger women.

show abstract

Section: Discussionsupporting

confidence: 79%

Values and worries of ovarian cancer patients

Pisu

Kenzik

Rim

et al. 2017

Gynecologic Oncology

View full text Add to dashboard Cite

show abstract

“…Additionally, income remained as a significant covariate in the final multivariate model. Financial burden faced by young adult cancer survivors can be tremendous and is associated with worry about achieving parenthood goals, which may require additional expenses (ie, via adoption or assisted reproductive technology) . Access and financial barriers to FC and FP exist globally.…”

Section: Discussionmentioning

confidence: 99%

“…ity, or partner status; however, those who utilized FC were more likely to have a higher income, be more recently diagnosed, not have a bioadult cancer survivors can be tremendous31,32 and is associated with worry about achieving parenthood goals, which may require additional expenses (ie, via adoption or assisted reproductive technology) 12,33. Access and financial barriers to FC and FP exist globally.…”

mentioning

confidence: 99%

Applying behavioral theory to understand fertility consultation uptake after cancer

et al. 2019

View full text Add to dashboard Cite

Objective The objective of this study was to examine the association between theoretical constructs from the Health Belief Model and fertility consultation status after cancer. Methods Reproductive‐aged female cancer survivors self‐reported their use of fertility consultation, perceived severity of and susceptibility to infertility, perceived barriers to and effectiveness of fertility consultation, and cues to action from family/peers and doctors, as well as demographics and cancer characteristics. Logistic regression was used to analyze the association between theoretical constructs and fertility consultation status. Results Fertility consultation uptake was more prevalent among survivors with higher incomes, those without children, those who wanted a (another) child, and those who were diagnosed more recently. In the final multivariate model, higher perceived severity of infertility, fewer perceived barriers to fertility consultation, and more cues to action from family/peers and doctors were significantly associated with fertility consultation uptake, controlling for income. Exploratory bivariate analyses of barriers to fertility consultation revealed that cost and trouble accessing services were significantly associated with not having a fertility consultation. Conclusions The Health Belief Model is useful for understanding factors associated with fertility consultation uptake. Efforts should be made to reduce financial barriers and improve patient‐centered assessment of family‐building goals.

show abstract

“…10 An increasing number of reports correlate quality of life with financial toxicity, or the financial impact of cancer care. [43][44][45] This has led to the development of financial toxicity survey tools, such as the 11-part Comprehensive Score for Financial Toxicity (COST), which demonstrated good correlation with a validated patient-reported outcome measure. 46 From the perspective of financial burden, patients with thyroid cancer were found to have one of the highest rates of bankruptcy compared with other cancer types.…”

Section: Effects On Survivorsmentioning

confidence: 99%

“…An increasing number of reports correlate quality of life with financial toxicity, or the financial impact of cancer care . This has led to the development of financial toxicity survey tools, such as the 11‐part Comprehensive Score for Financial Toxicity (COST), which demonstrated good correlation with a validated patient‐reported outcome measure .…”

Section: Introductionmentioning

confidence: 99%

The changing landscape of papillary thyroid cancer: Epidemiology, management, and the implications for patients

Lubitz

Sosa

2016

Cancer

View full text Add to dashboard Cite

The incidence of thyroid cancer has tripled over the past 3 decades, with the vast majority of the increase noted to be among small, indolent papillary thyroid carcinomas. Substantial overdiagnosis and potential overtreatment have led to a shift in clinical practice toward less aggressive approaches and a focus on improved risk stratification. This shift in practice may be associated with recent evidence suggesting that the increase in the incidence of thyroid cancer is slowing. Because patients are often young when they are diagnosed with thyroid cancer and because there is excellent long-term, disease-specific survival, there is an ever-growing population of survivors of thyroid cancer in the United States who accumulate substantial associated health care costs as they undergo surveillance and/or remedial treatment. Survivors of thyroid cancer can experience significant detriments to their quality of life and endure financial hardship. Future research should focus on the appropriateness of treatment as well as the financial and quality-of-life effects of thyroid cancer survivorship. Cancer 2016;122:3754-3759. © 2016 American Cancer Society.

show abstract

Financial toxicity in cancer care

Cited by 44 publications

References 46 publications

Values and worries of ovarian cancer patients

Values and worries of ovarian cancer patients

Applying behavioral theory to understand fertility consultation uptake after cancer

The changing landscape of papillary thyroid cancer: Epidemiology, management, and the implications for patients

Contact Info

Product

Resources

About